Study of T900607-Sodium in Previously Treated Patients With Non-Hodgkin's Lymphoma.

Status:
Terminated

Trial end date:
2003-03-01

Target enrollment:

Participant gender:

The purpose of the study is to determine whether T900607-sodium is effective and safe in treating non-Hodgkin's lymphoma.

Phase 2

Tularik